Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays
Prospective Collection of Female First-catch Urine, Vaginal Swab,Cervical, and Endocervical Swab Specimens for Testing With the APTIMA Assays
Status: Enrolling
Updated:  1/29/2014
Mount Vernon Clinical Research, LLC
423
mi
from 43215
Sandy Springs, GA
Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays
Prospective Collection of Female First-catch Urine, Vaginal Swab,Cervical, and Endocervical Swab Specimens for Testing With the APTIMA Assays
Status: Enrolling
Updated: 1/29/2014
Mount Vernon Clinical Research, LLC
423
mi
from 43215
Sandy Springs, GA
Click here to add this to my saved trials
Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays
Prospective Collection of Female First-catch Urine, Vaginal Swab,Cervical, and Endocervical Swab Specimens for Testing With the APTIMA Assays
Status: Enrolling
Updated:  1/29/2014
Louisiana State University Health Sciences Center Dept. of Medicine, Infectious Disease
797
mi
from 43215
New Orleans, LA
Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays
Prospective Collection of Female First-catch Urine, Vaginal Swab,Cervical, and Endocervical Swab Specimens for Testing With the APTIMA Assays
Status: Enrolling
Updated: 1/29/2014
Louisiana State University Health Sciences Center Dept. of Medicine, Infectious Disease
797
mi
from 43215
New Orleans, LA
Click here to add this to my saved trials
Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays
Prospective Collection of Female First-catch Urine, Vaginal Swab,Cervical, and Endocervical Swab Specimens for Testing With the APTIMA Assays
Status: Enrolling
Updated:  1/29/2014
John Hopkins University
344
mi
from 43215
Baltimore, MD
Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays
Prospective Collection of Female First-catch Urine, Vaginal Swab,Cervical, and Endocervical Swab Specimens for Testing With the APTIMA Assays
Status: Enrolling
Updated: 1/29/2014
John Hopkins University
344
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays
Prospective Collection of Female First-catch Urine, Vaginal Swab,Cervical, and Endocervical Swab Specimens for Testing With the APTIMA Assays
Status: Enrolling
Updated:  1/29/2014
New England Center for Clinical Research
631
mi
from 43215
Fall River, MA
Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays
Prospective Collection of Female First-catch Urine, Vaginal Swab,Cervical, and Endocervical Swab Specimens for Testing With the APTIMA Assays
Status: Enrolling
Updated: 1/29/2014
New England Center for Clinical Research
631
mi
from 43215
Fall River, MA
Click here to add this to my saved trials
Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays
Prospective Collection of Female First-catch Urine, Vaginal Swab,Cervical, and Endocervical Swab Specimens for Testing With the APTIMA Assays
Status: Enrolling
Updated:  1/29/2014
University of North Carolina at Chapel Hill
344
mi
from 43215
Chapel Hill, NC
Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays
Prospective Collection of Female First-catch Urine, Vaginal Swab,Cervical, and Endocervical Swab Specimens for Testing With the APTIMA Assays
Status: Enrolling
Updated: 1/29/2014
University of North Carolina at Chapel Hill
344
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays
Prospective Collection of Female First-catch Urine, Vaginal Swab,Cervical, and Endocervical Swab Specimens for Testing With the APTIMA Assays
Status: Enrolling
Updated:  1/29/2014
Cincinnati Children's Hospital Medical Center Division of Pediatric & Adolescent Gynecology
94
mi
from 43215
Cincinnati, OH
Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays
Prospective Collection of Female First-catch Urine, Vaginal Swab,Cervical, and Endocervical Swab Specimens for Testing With the APTIMA Assays
Status: Enrolling
Updated: 1/29/2014
Cincinnati Children's Hospital Medical Center Division of Pediatric & Adolescent Gynecology
94
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays
Prospective Collection of Female First-catch Urine, Vaginal Swab,Cervical, and Endocervical Swab Specimens for Testing With the APTIMA Assays
Status: Enrolling
Updated:  1/29/2014
Planned Parenthood Southeastern Pennsylvania
416
mi
from 43215
Philadelphia, PA
Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays
Prospective Collection of Female First-catch Urine, Vaginal Swab,Cervical, and Endocervical Swab Specimens for Testing With the APTIMA Assays
Status: Enrolling
Updated: 1/29/2014
Planned Parenthood Southeastern Pennsylvania
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays
Prospective Collection of Female First-catch Urine, Vaginal Swab,Cervical, and Endocervical Swab Specimens for Testing With the APTIMA Assays
Status: Enrolling
Updated:  1/29/2014
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays
Prospective Collection of Female First-catch Urine, Vaginal Swab,Cervical, and Endocervical Swab Specimens for Testing With the APTIMA Assays
Status: Enrolling
Updated: 1/29/2014
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays
Prospective Collection of Female First-catch Urine, Vaginal Swab,Cervical, and Endocervical Swab Specimens for Testing With the APTIMA Assays
Status: Enrolling
Updated:  1/29/2014
Jackson Clinic, PA
436
mi
from 43215
Jackson, TN
Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays
Prospective Collection of Female First-catch Urine, Vaginal Swab,Cervical, and Endocervical Swab Specimens for Testing With the APTIMA Assays
Status: Enrolling
Updated: 1/29/2014
Jackson Clinic, PA
436
mi
from 43215
Jackson, TN
Click here to add this to my saved trials
Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays
Prospective Collection of Female First-catch Urine, Vaginal Swab,Cervical, and Endocervical Swab Specimens for Testing With the APTIMA Assays
Status: Enrolling
Updated:  1/29/2014
Planned Parenthood Gulf Coast
991
mi
from 43215
Houston, TX
Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays
Prospective Collection of Female First-catch Urine, Vaginal Swab,Cervical, and Endocervical Swab Specimens for Testing With the APTIMA Assays
Status: Enrolling
Updated: 1/29/2014
Planned Parenthood Gulf Coast
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays
Prospective Collection of Female First-catch Urine, Vaginal Swab,Cervical, and Endocervical Swab Specimens for Testing With the APTIMA Assays
Status: Enrolling
Updated:  1/29/2014
Tidewater Clinical Research
423
mi
from 43215
Norfolk, VA
Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays
Prospective Collection of Female First-catch Urine, Vaginal Swab,Cervical, and Endocervical Swab Specimens for Testing With the APTIMA Assays
Status: Enrolling
Updated: 1/29/2014
Tidewater Clinical Research
423
mi
from 43215
Norfolk, VA
Click here to add this to my saved trials
Relative Bioavailability, Safety, Tolerability, Pharmacokinetics (PK) and Food Effect Study of GSK2140944 in Healthy Subjects
A Single-Center, Three-Part, Open Label Study to Evaluate the Relative Bioavailability of Two Formulations, Food Effect, and Interaction With Itraconazole Following Single Dose of GSK2140944 in Healthy Subjects and Effect of Food on Safety, Tolerability, and Pharmacokinetics Following Multiple Doses of GSK2140944 in Healthy Elderly Subjects
Status: Enrolling
Updated:  2/6/2014
GSK Investigational Site
626
mi
from 43215
Overland Park, KA
Relative Bioavailability, Safety, Tolerability, Pharmacokinetics (PK) and Food Effect Study of GSK2140944 in Healthy Subjects
A Single-Center, Three-Part, Open Label Study to Evaluate the Relative Bioavailability of Two Formulations, Food Effect, and Interaction With Itraconazole Following Single Dose of GSK2140944 in Healthy Subjects and Effect of Food on Safety, Tolerability, and Pharmacokinetics Following Multiple Doses of GSK2140944 in Healthy Elderly Subjects
Status: Enrolling
Updated: 2/6/2014
GSK Investigational Site
626
mi
from 43215
Overland Park, KA
Click here to add this to my saved trials
Vouchers to Promote Tdap Vaccination
Retail Pharmacy Vouchers to Promote Tdap Vaccination for Adults Living With Infants
Status: Enrolling
Updated:  2/20/2014
Karabots Primary Care Center - The Children's Hospital of Philadelphia
mi
from 43215
Philadelphia, PA
Vouchers to Promote Tdap Vaccination
Retail Pharmacy Vouchers to Promote Tdap Vaccination for Adults Living With Infants
Status: Enrolling
Updated: 2/20/2014
Karabots Primary Care Center - The Children's Hospital of Philadelphia
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Effects of SQ109 on QTc Interval in Healthy Subjects
Phase 1 Crossover Study to Assess the Effects of SQ109 on QTc Interval in Healthy Subjects
Status: Enrolling
Updated:  2/20/2014
Case Western Reserve University - Case Medical Center - Infectious Disease & HIV Medicine
127
mi
from 43215
Cleveland, OH
Effects of SQ109 on QTc Interval in Healthy Subjects
Phase 1 Crossover Study to Assess the Effects of SQ109 on QTc Interval in Healthy Subjects
Status: Enrolling
Updated: 2/20/2014
Case Western Reserve University - Case Medical Center - Infectious Disease & HIV Medicine
127
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
In Vitro Diagnostic Device for the Detection of Strep A
Multi-Center Study of an In Vitro Diagnostic Device for the Detection of Strep A
Status: Enrolling
Updated:  2/20/2014
Norwich Pediatrics
582
mi
from 43215
Norwich, CT
In Vitro Diagnostic Device for the Detection of Strep A
Multi-Center Study of an In Vitro Diagnostic Device for the Detection of Strep A
Status: Enrolling
Updated: 2/20/2014
Norwich Pediatrics
582
mi
from 43215
Norwich, CT
Click here to add this to my saved trials
In Vitro Diagnostic Device for the Detection of Strep A
Multi-Center Study of an In Vitro Diagnostic Device for the Detection of Strep A
Status: Enrolling
Updated:  2/20/2014
Meridian Clinical Research, LLC
561
mi
from 43215
Savannah, GA
In Vitro Diagnostic Device for the Detection of Strep A
Multi-Center Study of an In Vitro Diagnostic Device for the Detection of Strep A
Status: Enrolling
Updated: 2/20/2014
Meridian Clinical Research, LLC
561
mi
from 43215
Savannah, GA
Click here to add this to my saved trials
In Vitro Diagnostic Device for the Detection of Strep A
Multi-Center Study of an In Vitro Diagnostic Device for the Detection of Strep A
Status: Enrolling
Updated:  2/20/2014
Twelve Corners Pediatrics
356
mi
from 43215
Rochester, NY
In Vitro Diagnostic Device for the Detection of Strep A
Multi-Center Study of an In Vitro Diagnostic Device for the Detection of Strep A
Status: Enrolling
Updated: 2/20/2014
Twelve Corners Pediatrics
356
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
In Vitro Diagnostic Device for the Detection of Strep A
Multi-Center Study of an In Vitro Diagnostic Device for the Detection of Strep A
Status: Enrolling
Updated:  2/20/2014
Plano Pediatrics
901
mi
from 43215
Plano, TX
In Vitro Diagnostic Device for the Detection of Strep A
Multi-Center Study of an In Vitro Diagnostic Device for the Detection of Strep A
Status: Enrolling
Updated: 2/20/2014
Plano Pediatrics
901
mi
from 43215
Plano, TX
Click here to add this to my saved trials
In Vitro Diagnostic Device for the Detection of Strep A
Multi-Center Study of an In Vitro Diagnostic Device for the Detection of Strep A
Status: Enrolling
Updated:  2/20/2014
Advanced Pediatrics
316
mi
from 43215
Vienna, VA
In Vitro Diagnostic Device for the Detection of Strep A
Multi-Center Study of an In Vitro Diagnostic Device for the Detection of Strep A
Status: Enrolling
Updated: 2/20/2014
Advanced Pediatrics
316
mi
from 43215
Vienna, VA
Click here to add this to my saved trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated:  2/24/2014
Growing Up Pediatrics
505
mi
from 43215
Bessemer, AL
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated: 2/24/2014
Growing Up Pediatrics
505
mi
from 43215
Bessemer, AL
Click here to add this to my saved trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated:  2/24/2014
Alabama Clinical Therapeutics, Llc
482
mi
from 43215
Birmingham, AL
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated: 2/24/2014
Alabama Clinical Therapeutics, Llc
482
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated:  2/24/2014
Growing Up Pediatrics
495
mi
from 43215
Birmingham, AL
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated: 2/24/2014
Growing Up Pediatrics
495
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated:  2/24/2014
Premier Health Research Center
1969
mi
from 43215
Downey, CA
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated: 2/24/2014
Premier Health Research Center
1969
mi
from 43215
Downey, CA
Click here to add this to my saved trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated:  2/24/2014
Kaiser Permanente-Oakland
2094
mi
from 43215
Oakland, CA
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated: 2/24/2014
Kaiser Permanente-Oakland
2094
mi
from 43215
Oakland, CA
Click here to add this to my saved trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated:  2/24/2014
Kaiser Permanente Med Group - Vaccine Study Ctr
2098
mi
from 43215
Oakland, CA
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated: 2/24/2014
Kaiser Permanente Med Group - Vaccine Study Ctr
2098
mi
from 43215
Oakland, CA
Click here to add this to my saved trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated:  2/24/2014
Center for Clinical Trials, LLC.
1971
mi
from 43215
Paramount, CA
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated: 2/24/2014
Center for Clinical Trials, LLC.
1971
mi
from 43215
Paramount, CA
Click here to add this to my saved trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated:  2/24/2014
Kaiser Permanente - Pleasanton
2081
mi
from 43215
Pleasanton, CA
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated: 2/24/2014
Kaiser Permanente - Pleasanton
2081
mi
from 43215
Pleasanton, CA
Click here to add this to my saved trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated:  2/24/2014
Kaiser Permanente-Richmond
2100
mi
from 43215
Richmond, CA
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated: 2/24/2014
Kaiser Permanente-Richmond
2100
mi
from 43215
Richmond, CA
Click here to add this to my saved trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated:  2/24/2014
Kaiser Permanente-San Francisco
2107
mi
from 43215
San Francisco, CA
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated: 2/24/2014
Kaiser Permanente-San Francisco
2107
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated:  2/24/2014
Kaiser Permanente Santa Clara
2091
mi
from 43215
Santa Clara, CA
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated: 2/24/2014
Kaiser Permanente Santa Clara
2091
mi
from 43215
Santa Clara, CA
Click here to add this to my saved trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated:  2/24/2014
UCLA Center for Vaccine Research
1980
mi
from 43215
Torrence, CA
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated: 2/24/2014
UCLA Center for Vaccine Research
1980
mi
from 43215
Torrence, CA
Click here to add this to my saved trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated:  2/24/2014
Children'S Hospital
1154
mi
from 43215
Aurora, CO
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated: 2/24/2014
Children'S Hospital
1154
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated:  2/24/2014
Longmont Medical Research Network
1165
mi
from 43215
Longmont, CO
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated: 2/24/2014
Longmont Medical Research Network
1165
mi
from 43215
Longmont, CO
Click here to add this to my saved trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated:  2/24/2014
Children's Memorial Hospital
274
mi
from 43215
Chicago, IL
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated: 2/24/2014
Children's Memorial Hospital
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated:  2/24/2014
Kentucky Pediatric/ Adult Research
198
mi
from 43215
Bardstown, KY
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated: 2/24/2014
Kentucky Pediatric/ Adult Research
198
mi
from 43215
Bardstown, KY
Click here to add this to my saved trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated:  2/24/2014
Annapolis Pediatrics
353
mi
from 43215
Annapolis, MD
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated: 2/24/2014
Annapolis Pediatrics
353
mi
from 43215
Annapolis, MD
Click here to add this to my saved trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated:  2/24/2014
Center for Vaccine Development
343
mi
from 43215
Baltimore, MD
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated: 2/24/2014
Center for Vaccine Development
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated:  2/24/2014
The Pediatric Center
300
mi
from 43215
Frederick, MD
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated: 2/24/2014
The Pediatric Center
300
mi
from 43215
Frederick, MD
Click here to add this to my saved trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated:  2/24/2014
Boston University Medical Center
643
mi
from 43215
Boston, MA
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated: 2/24/2014
Boston University Medical Center
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated:  2/24/2014
Pediatric Associates of Fall River
630
mi
from 43215
Fall River, MA
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated: 2/24/2014
Pediatric Associates of Fall River
630
mi
from 43215
Fall River, MA
Click here to add this to my saved trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated:  2/24/2014
Creighton University
683
mi
from 43215
Omaha, NE
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated: 2/24/2014
Creighton University
683
mi
from 43215
Omaha, NE
Click here to add this to my saved trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated:  2/24/2014
Children's Physicians Dundee
685
mi
from 43215
Omaha, NE
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated: 2/24/2014
Children's Physicians Dundee
685
mi
from 43215
Omaha, NE
Click here to add this to my saved trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated:  2/24/2014
Dartmouth Hitchcock Medical Center
609
mi
from 43215
Lebanon, NH
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated: 2/24/2014
Dartmouth Hitchcock Medical Center
609
mi
from 43215
Lebanon, NH
Click here to add this to my saved trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated:  2/24/2014
Montefiore Medical Center
484
mi
from 43215
Bronx, NY
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated: 2/24/2014
Montefiore Medical Center
484
mi
from 43215
Bronx, NY
Click here to add this to my saved trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated:  2/24/2014
Akron Children's Hospital
110
mi
from 43215
Akron, OH
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated: 2/24/2014
Akron Children's Hospital
110
mi
from 43215
Akron, OH
Click here to add this to my saved trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated:  2/24/2014
Louis P. Brine, Jr., MD, Beeghley Medical Park
144
mi
from 43215
Boardman, OH
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated: 2/24/2014
Louis P. Brine, Jr., MD, Beeghley Medical Park
144
mi
from 43215
Boardman, OH
Click here to add this to my saved trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated:  2/24/2014
Senders Pediatric Research at Dr. Senders and Associates
132
mi
from 43215
Cleveland, OH
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated: 2/24/2014
Senders Pediatric Research at Dr. Senders and Associates
132
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated:  2/24/2014
Carnegie Pediatrics
158
mi
from 43215
Carnegie, PA
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated: 2/24/2014
Carnegie Pediatrics
158
mi
from 43215
Carnegie, PA
Click here to add this to my saved trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated:  2/24/2014
Children's Health Care - West
213
mi
from 43215
Erie, PA
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated: 2/24/2014
Children's Health Care - West
213
mi
from 43215
Erie, PA
Click here to add this to my saved trials
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated:  2/24/2014
UPMC / Community Medicine Inc
171
mi
from 43215
Greenville, PA
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Status: Enrolling
Updated: 2/24/2014
UPMC / Community Medicine Inc
171
mi
from 43215
Greenville, PA
Click here to add this to my saved trials